EligibleTrials

Clinical trials recruiting for Uterine Cervical Neoplasms

5
Recruiting trials
22
US states with sites
11
Countries
20%
Accept healthy volunteers

Phase breakdown

Phase 1 4Phase 2 2Not applicable 1

Drugs and treatments being studied

InterventionTrials
Carboplatin2
Pembrolizumab2
Bevacizumab1
Cisplatin1
HTL0039732 Capsules1
HTL0039732 Capsules and atezolizumab infusion1
Itraconazole1
LY41701561
Sigvotatug Vedotin1
UCB45941

Where trials are recruiting (top US states)

StateRecruiting trials
California2
New York2
Ohio2
Texas2
Alaska1
Arizona1
Arkansas1
Florida1
Illinois1
Indiana1
Kansas1
Massachusetts1

Top cities

Houston, Texas 2New York, New York 2Anaheim, California 1Anchorage, Alaska 1Babylon, New York 1Bonney Lake, Washington 1Boston, Massachusetts 1Brooklyn, New York 1Calumet City, Illinois 1Chicago, Illinois 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Uterine Cervical Neoplasms often also study these conditions. Each links to its own recruiting-trial list.

Pancreatic cancer 870Lung cancer 2180Colorectal Neoplasms 61Stomach Neoplasms 11Ovarian Neoplasms 18Colorectal cancer 1359Non-small cell lung cancer 507Breast cancer 2239Urinary Bladder Neoplasms 4Triple Negative Breast Neoplasms 12

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Uterine Cervical Neoplasms trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.